Medco Research to explore uses of genetic biomarkers; Study explores role of proteins as biomarker for colon cancer

>  The Medco Research Institute and SureGene are collaborating on new research that sheds light on the connection between variations in genetic biomarkers and the efficacy of antipsychotic therapies. Report

> A new study explores the role of hydrophobic proteins as biomarkers for colon cancer. Release

> The FDA has selected Ariana Pharma's Knowledge Extraction Management decision-support platform for biomarker signature validation work. Ariana release

> The Biomedical Advanced Research and Development Authority awarded Menssana Research a contract for $4.2 million plus options--which could total $22.84 million, if exercised--to develop a breath test for radiation exposure. Menssana Research has developed a breathalyzer which can detect several hundred different chemical compounds in normal human breath. Menssana release

> Emerald BioStructures and SomaLogic will collaborate on new technology needed to design and optimize SOMAmers for use in diagnostics and biomarker discovery. Story

Suggested Articles

The FDA has cleared its first fully disposable duodenoscope, following years of reports of infections being transmitted between patients.

OR-focused AI provider Caresyntax has garnered $45.6 million in new funding and picked up a data analytics firm to broaden its footprint.

A study of Foundation Medicine’s FoundationOne liquid biopsy test found it was able to predict the risk that a person’s breast cancer would return.